COLLABORATIVE STUDY OF THE GENETICS OF ASTHMA (CSGA)
哮喘遗传学合作研究 (CSGA)
基本信息
- 批准号:6183248
- 负责人:
- 金额:$ 72.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:asthma clinical research cooperative study disease /disorder proneness /risk family genetics gene environment interaction genetic markers genetic models genetic polymorphism genotype human population genetics human subject immunologic skin test linkage mapping medical records racial /ethnic difference respiratory disorder diagnosis
项目摘要
Epidemiologic data indicate that a major risk factor for asthma is a
positive family history. However, genes that confer susceptibility to
asthma are unknown. We propose to identify asthma susceptibility loci by
performing two-point and complex linkage analysis with microsatellite
markers distributed throughout the genome in families with well-defined
asthma. Our study will focus on two distinct samples: Chicago inner-city
and suburban families ascertained through the pediatric and adult asthma
clinics at the University of Chicago and members of the Hutterite
brethren, a religious isolate that lives on communal farms in South
Dakota. The latter population has previously been characterized with
respect to asthma and other respiratory illnesses. We propose to study
150 clinic families (average family size = 10) and eight
multigenerational Hutterite families. Families will be selected through
asthmatic probands who have at least one first degree relative with
asthma. The diagnosis of asthma in affected and unaffected subjects will
be made using strict criteria based on medical history and results of
spirometry and methacholine challenge studies. Skin tests for commonly
inhaled antigens will be performed, and IgE levels and eosinophil counts
will be measured on all subjects. All family members will be genotype
for up to 300 polymorphic DNA markers (microsatellite markers) that map
near "candidate susceptibility loci" or are distributed randomly
throughout the genome. Permanent lines will be established or cells
derived from all subjects. Preliminary screening of genetic data will be
performed using two-point linkage analysis, considering two genetic
models that include a disease prevalence of 10 and assume heterogeneity
but vary with respect to penetrance and the proportional contribution of
the susceptibility locus (20% vs. 40%). A two-point lod score greater
than 2.0 under any genetic model will be subjected to further
investigation using nonparametric tests, multipoint linkage analysis, and
more sophisticated genetic models that incorporate additional genetic and
environmental covariates. If linkage to a susceptibility locus is found,
attempts will be make to identify and clone the susceptibility locus.
Once susceptibility alleles are known, preventive measures can focus on
individuals at-risk for developing asthma. Identifying asthma
susceptibility alleles would also contribute toward elucidating the
primary defect in asthma and advance the development of improved
treatments.
流行病学数据表明,哮喘的主要危险因素是
阳性家族史。 然而,赋予易感性的基因,
哮喘未知。 我们建议通过以下方法来确定哮喘易感位点:
用微卫星进行两点和复杂连锁分析
分布在整个基因组中的家族标记,
哮喘 我们的研究将集中在两个不同的样本:芝加哥内城
和郊区家庭通过儿童和成人哮喘
芝加哥大学的诊所和哈特派成员
兄弟们,一个生活在南部公共农场的宗教隔离者,
达科他州 后一种人群以前被描述为
哮喘和其他呼吸道疾病。 我们建议研究
150个诊所家庭(平均家庭规模= 10)和8个
几代同堂的哈特家族将通过以下方式选择家庭:
哮喘先证者至少有一个一级亲属,
哮喘受影响和未受影响受试者的哮喘诊断将
使用基于病史和结果的严格标准进行
肺量测定和乙酰甲胆碱激发研究。 皮肤测试通常
将进行吸入抗原检测,检测IgE水平和嗜酸性粒细胞计数
将在所有科目上进行测量。 所有的家庭成员将基因型
多达300个多态性DNA标记(微卫星标记),
在“候选易感位点”附近或随机分布
整个基因组。 将建立永久线路或单元
来自所有科目。 基因数据的初步筛选将
使用两点连锁分析进行,考虑到两个遗传
包括疾病患病率为10并假设异质性的模型
但随着温度和比例的贡献而变化,
易感位点(20% vs. 40%)。两个点的lod得分大于
在任何遗传模型下,2.0将受到进一步的
使用非参数检验、多点连锁分析和
更复杂的遗传模型,包括额外的遗传和
环境协变量 如果发现与易感基因座的连锁,
将尝试鉴定和克隆易感性基因座。
一旦知道了易感等位基因,预防措施可以集中在
有患哮喘风险的人。 识别哮喘
易感性等位基因也有助于阐明
哮喘的原发性缺陷,并推进改善的发展
治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carole Ober其他文献
Carole Ober的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carole Ober', 18)}}的其他基金
Gene Discovery in Asthma and Allergic Diseases
哮喘和过敏性疾病的基因发现
- 批准号:
10453776 - 财政年份:2021
- 资助金额:
$ 72.44万 - 项目类别:
Gene Discovery in Asthma and Allergic Diseases
哮喘和过敏性疾病的基因发现
- 批准号:
10261990 - 财政年份:2021
- 资助金额:
$ 72.44万 - 项目类别:
Gene Discovery in Asthma and Allergic Diseases
哮喘和过敏性疾病的基因发现
- 批准号:
10827534 - 财政年份:2021
- 资助金额:
$ 72.44万 - 项目类别:
Maternal asthma and epigenomic modification in offspring with asthma
母亲哮喘和哮喘后代的表观基因组修饰
- 批准号:
9312388 - 财政年份:2016
- 资助金额:
$ 72.44万 - 项目类别:
Mendelian Disease - Asthma Comorbidity to Find Subgroup-Specific Asthma Genes
孟德尔病 - 哮喘合并症寻找亚组特异性哮喘基因
- 批准号:
8875986 - 财政年份:2015
- 资助金额:
$ 72.44万 - 项目类别:
Mendelian Disease - Asthma Comorbidity to Find Subgroup-Specific Asthma Genes
孟德尔病 - 哮喘合并症寻找亚组特异性哮喘基因
- 批准号:
9300966 - 财政年份:2015
- 资助金额:
$ 72.44万 - 项目类别:
Mendelian Disease - Asthma Comorbidity to Find Subgroup-Specific Asthma Genes
孟德尔病 - 哮喘合并症寻找亚组特异性哮喘基因
- 批准号:
9130935 - 财政年份:2015
- 资助金额:
$ 72.44万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 72.44万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 72.44万 - 项目类别: